Is EIKN or ENTX more undervalued in 2026?

CirclFi compares Eikon Therapeutics, Inc. (EIKN) and Entera Bio Ltd. (ENTX) using 13 institutional-grade valuation models. EIKN has a Quality of Company score of 1.7/10 while ENTX scores 5.6/10.

Which is a better buy — EIKN or ENTX?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do EIKN and ENTX valuations compare?

EIKN at $10.84 and ENTX at $1.35 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

EIKN vs ENTX Valuation Comparison 2026 — Intrinsic Value Analysis

EIKN

Biological Products, (No Diagnostic Substances)

Eikon Therapeutics, Inc.

Quality

1.7

out of 10

Value Trap

—

Price

$10.84

Last close

Models

7/13

Active

ENTX

Biological Products, (No Diagnostic Substances)

Entera Bio Ltd.

Quality

5.6

out of 10

Value Trap

WARN

Price

$1.35

Last close

Models

11/13

Active

Model-by-Model Comparison

Model	Type	EIKN Fair Value	EIKN Upside	ENTX Fair Value	ENTX Upside
Bayesian DCF	Intrinsic	$2.80	-74.1%	$0.37	-72.8%
Earnings Power Value	Intrinsic	—	—	$0.16	-85.5%
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$•••.••	••.•%	$•••.••	••.•%
PWERM	Option-Based	$5.58	-48.5%	$1.19	-11.6%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for EIKN vs ENTX — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

EIKN vs ENTX — Which Stock Is More Undervalued?

ENTX scores higher with a 5.6/10 quality rating vs EIKN's 1.7/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Eikon Therapeutics, Inc. (EIKN) and Entera Bio Ltd. (ENTX) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

EIKN currently trades at $10.84 with a QOC of 1.7/10, while ENTX trades at $1.35 with a QOC of 5.6/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).